Childress Capital Advisors, LLC Eli Lilly & CO Transaction History

Childress Capital Advisors, LLC

$366 Million
Q3 2024

A detailed history of Childress Capital Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Childress Capital Advisors, LLC holds 2,445 shares of LLY stock, worth $1.95 Million. This represents 0.59% of its overall portfolio holdings.

Number of Shares

2,445

Previous 2,340 4.49%

Holding current value

$1.95 Million

Previous $2.12 Million 2.27%

% of portfolio

0.59%

Previous 0.61%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	BUY	$772.14 - $960.02 $81,074 - $100,802	105 Added 4.49%	2,445 $2.17 Million
Q2 2024 Aug 05, 2024	BUY	$724.87 - $909.04 $43,492 - $54,542	60 Added 2.63%	2,340 $2.12 Million
Q1 2024 Apr 24, 2024	SELL	$592.2 - $792.28 $123,177 - $164,794	-208 Reduced 8.36%	2,280 $1.77 Million
Q4 2023 Feb 16, 2024	SELL	$525.19 - $619.13 $12,079 - $14,239	-23 Reduced 0.92%	2,488 $1.45 Million
Q3 2023 Nov 06, 2023	BUY	$434.7 - $599.3 $846,795 - $1.17 Million	1,948 Added 346.0%	2,511 $1.35 Million
Q2 2023 Aug 11, 2023	SELL	$350.74 - $468.98 $179,228 - $239,648	-511 Reduced 47.58%	563 $264,000
Q1 2023 May 12, 2023	SELL	$310.63 - $364.82 $532,109 - $624,936	-1,713 Reduced 61.46%	1,074 $368,000
Q4 2022 Feb 03, 2023	BUY	$321.55 - $374.67 $19,936 - $23,229	62 Added 2.28%	2,787 $1.02 Million
Q3 2022 Nov 03, 2022	SELL	$296.48 - $337.87 $34,984 - $39,868	-118 Reduced 4.15%	2,725 $892,000
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $58,533 - $68,726	210 Added 7.98%	2,843 $922,000
Q1 2022 May 10, 2022	BUY	$234.69 - $291.66 $94,345 - $117,247	402 Added 18.02%	2,633 $755,000
Q4 2021 Jan 26, 2022	BUY	$224.85 - $279.04 $12,816 - $15,905	57 Added 2.62%	2,231 $616,000
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $25,040 - $30,816	113 Added 5.48%	2,174 $502,000
Q2 2021 Jul 28, 2021	BUY	$180.55 - $233.54 $61,387 - $79,403	340 Added 19.76%	2,061 $473,000
Q1 2021 May 21, 2021	BUY	$164.32 - $212.72 $172,207 - $222,930	1,048 Added 155.72%	1,721 $321,000
Q4 2020 Mar 09, 2021	BUY	$130.46 - $172.63 $87,799 - $116,179	673 New	673 $116,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Childress Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Childress Capital Advisors, LLC with notifications on news.

Account

Childress Capital Advisors, LLC Eli Lilly & CO Transaction History